Insulin Delivery Devices Market - PowerPoint PPT Presentation

About This Presentation

Insulin Delivery Devices Market


Global Insulin Delivery Devices Market is estimated to reach $22.8 billion by 2024; growing at a CAGR of 8.9% from 2016 to 2024. – PowerPoint PPT presentation

Number of Views:104


Transcript and Presenter's Notes

Title: Insulin Delivery Devices Market

 Global Insulin Delivery Devices Market Is
Estimated To Reach 22.8 Billion By 2024, Says
Variant Market Research
Manoj Kumkar SEO
Insulin Delivery Devices Market
Global Insulin Delivery Devices Market is
estimated to reach 22.8 billion by 2024 growing
at a CAGR of 8.9 from 2016 to 2024. Insulin is a
hormone made in the pancreas, which is essential
in regulating blood glucose levels. Insulin plays
a vital role in metabolism as the lack of insulin
production or inability to respond to insulin
leads to the development of diabetes. People with
type 1 and type 2 diabetes requires to take
insulin shots externally in order to prevent
long-term complications and to aid the body in
processing glucose and avoid complications
related to hyperglycemia. The most commonly
prescribed insulins for medication are synthetic
insulins, that are given through injection pen,
syringe, insulin pumps and other devices. The
type of devices used to deliver insulin varies
among end-users depending upon their ability to
operate, insulin regimen, and others. Get Browse
Complete Report _at_ https//www.variantmarketresearc
Insulin Delivery Devices Market Size and
Forecast, 2015 - 2024
Insulin Delivery Devices Market
Increasing number of geriatric and obesity
population, technological advancements in insulin
delivery systems, and favoring reimbursement
policies are the drivers boosting the growth of
the global insulin delivery devices market.
Moreover, increasing awareness among consumers on
availability of several delivery devices and
development of human insulin devices are also
fueling the growth of the market. However, high
cost of these devices and risks associated with
the misuse of drug delivery devices may hamper
the growth of the market. Furthermore, market
expansion and growing RD activities would
provide several opportunities for players in the
market. The global insulin delivery devices
market is bifurcated into device type and
geography. Device type is categorized into
insulin pumps, insulin syringes, insulin pens and
insulin jet injectors. Get Sample Report _at_
Insulin Delivery Devices Market share by region,
Major Key Players
  • Medtronic plc
  • Eli Lilly and Company
  • Becton
  • Dickinson and Company
  • Tandem Diabetes Care Inc.
  • Ypsomed Holding AG
  • F. Hoffmann-La Roche Ltd.
  • Animas Corporation
  • Novo Nordisk A/S
  • B. Braun Melsungen AG
  • Insulet Corporation
The Key Takeaways From The Report
  • The report will provide a detailed analysis of
    Global Insulin Delivery Devices Market with
    respect to major segments such as device type and
  • The report will include the qualitative and
    quantitative analysis with market estimation over
    2015-2024 and compound annual growth rate (CAGR)
    between 2016 and 2024
  • Comprehensive analysis of market dynamics
    including factors and opportunities will be
    provided in the report
  • An exhaustive regional analysis of Global Insulin
    Delivery Devices Market from 2015 to 2024 has
    been included in the report
  • Profile of the key players in the Global Insulin
    Delivery Devices Market will be provided, which
    include key financials, product services, new
    developments and business strategies
Scope Of The Global Insulin Delivery Devices
  • Device Type Segments
  • Insulin Pumps
  • Insulin Syringes
  • Insulin Pens
  • Insulin Jet Injectors
Table Of Content
Chapter 1 Prefix 1.1 Market Scope 1.2
Report Description 1.3 Research Methodology
1.3.1 Primary Research 1.3.2
Secondary Research 1.3.3 In-house Data
Modeling Chapter 2 Executive Summary
Table Of Content
Chapter 3 Market Outline 3.1 Market
Inclination, Trend, Outlook and Viewpoint 3.2
Market Share Analysis Companys Competitive
Scenario 3.3 Market Dynamics 3.3.1
Drivers Impact
Analysis 3.3.2 Restraints Impact Analysis 3.3.3
Opportunities ..
Table Of Content
Chapter 6 Company Profiles 6.1 Medtronic plc
6.2 Eli Lilly and Company 6.3 Becton,
Dickinson and Company 6.4 Tandem Diabetes
Care, Inc. 6.5 Ypsomed Holding AG 6.6 F.
Hoffmann-La Roche, Ltd. 6.7 Animas
Corporation 6.8 Novo Nordisk A/S 6.9 B.
Braun Melsungen AG 6.10 Insulet Corporation
Contact Us
  • Michael Mendes
  • Head - Sales
  • Variant Market Research
  • 649 Mission St, 5th Floor, San Francisco,
  • CA 94105,United States.
  • Tel 1-415-680-2785
  • Fax 1-415-680-2786
  • Email
  • Email
Thank You
Follow Us
  • Sample request

Linked in
Google Plus
Write a Comment
User Comments (0)